title: Low-dose growth hormone-releasing factor may enhance folliculogenesis in regularly menstruating women: a preliminary study.
abstract: OBJECTIVE
  To evaluate the effect of low-dose GH-releasing factor (GRF) on folliculogenesis in regularly menstruating women.
  
  
  METHODS
  Prospective clinical trial where individual patients served as their own control.
  
  
  METHODS
  Outpatient Reproductive Endocrine/Infertility Clinic of the Los Angeles County-University of Southern California Medical Center, Los Angeles, California.
  
  
  METHODS
  Seven regularly menstruating women.
  
  
  METHODS
  During treatment cycles, subjects received 100 micrograms SC GRF on cycle days 2 to 11 and were observed during a control cycle.
  
  
  METHODS
  Follicle number and diameter, as well as endometrial thickness were all assessed by vaginal ultrasound and blood was obtained for serum FSH, LH, E2, P, GH, insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein-3.
  
  
  RESULTS
  During cycles treated with GRF, GH, and IGF-1 levels were normal. However, follicular growth rates and E2 to FSH ratios were significantly higher. The day of the peak E2 to follicular diameter ratio after GRF was earlier than in control cycles. Endometrial growth rates were also greater with GRF.
  
  
  CONCLUSIONS
  Our data, although preliminary, support the hypothesis that low doses of GRF may independently stimulate the ovary and enhance folliculogenesis.
authors.affiliation: University of Southern California School of Medicine, Los Angeles.
authors.forename: D M
authors.initials: DM
authors.lastname: Duffy
authors.forename: S R
authors.initials: SR
authors.lastname: Lindheim
authors.forename: M A
authors.initials: MA
authors.lastname: Vijod
authors.forename: L
authors.initials: L
authors.lastname: Chang
authors.forename: R M
authors.initials: RM
authors.lastname: Nakamura
authors.forename: R A
authors.initials: RA
authors.lastname: Lobo
mesh_terms: D000328:Adult; D004717:Endometrium / Q000000981:diagnostic imaging / Q000187:drug effects / Q000254:growth & development; D004958:Estradiol / Q000097:blood; D005260:Female; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage* / Q000494:pharmacology; D006728:Hormones / Q000097:blood; D006801:Humans; D008597:Menstrual Cycle / Q000502:physiology*; D006080:Ovarian Follicle / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000254:growth & development*; D011446:Prospective Studies; D014463:Ultrasonography
chemical_list: D006728:Hormones; D004958:Estradiol; D013007:Growth Hormone-Releasing Hormone